Cat.#: ACPP-1257
| Despition | MC4 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1220 | ELOVL4 Blocking Peptide (AC1220) | 250 µg | inquiry |
| ACPP-1009 | Recombinant Human TYRO3 Protein (6×His Tag) (AC1009) | 50 µg | inquiry |
| ACPP-1201 | HAND2 Blocking Peptide (AC1201) | 250 µg | inquiry |
| ACPP-1641 | Adenylate cyclase 1 Blocking Peptide (AC1641) | 250 µg | inquiry |
| ACPP-1668 | Human BDNF Protein, His (AC1668) | 5 µg | inquiry |
| ACPP-1797 | Human S100A5 Protein (AC1797) | 5 µg | inquiry |
| ACPP-1077 | CaMKII gamma Blocking Peptide (AC1077) | 250 µg | inquiry |
| ACPP-1382 | Human EYA2 Protein (AC1382) | 2 µg | inquiry |
| ACPP-1618 | Human SYT11 Protein (AC1618) | 2 µg | inquiry |
| ACPP-1526 | Human KCTD11 Protein (AC1526) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.